Specificity of regulatory CD4+CD25+ T cells for self-T cell receptor determinants
✍ Scribed by Abigail C. Buenafe; Laura Tsaknaridis; Leslie Spencer; Kevin S. Hicks; Rachel H. McMahan; Lisa Watson; Nicole E. Culbertson; Dorian Latocha; Keith Wegmann; Tom Finn; Richard Bartholomew; Gregory G. Burrows; Ruth Whitham; Dennis N. Bourdette; Richard E. Jones; Halina Offner; Yuan K. Chou; Arthur A. Vandenbark
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 445 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although the phenotypic and regulatory properties of the CD4^+^CD25^+^ T cell lineage (Treg cells) have been well described, the specificities remain largely unknown. We demonstrate here that the CD4^+^CD25^+^ Treg population includes the recognition of a broad spectrum of human TCR CDR2 determinants found in the germline V gene repertoire as well as that of a clonotypic nongermline‐encoded CDR3β sequence present in a recombinant soluble T cell receptor (TCR) protein. Regulatory activity was demonstrated in T cell lines responsive to TCR but not in T cell lines responsive to control antigens. Inhibitory activity of TCR‐reactive T cells required cell–cell contact and involved CTLA‐4, GITR, IL‐10, and IL‐17. Thus, the T–T regulatory network includes Treg cells with specificity directed toward self‐TCR determinants. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Immunosuppressants are powerful drugs, capable of triggering severe adverse effects. Hence, there is tremendous interest in replacing them with less‐toxic agents. Adoptive therapy with CD25^+^CD4^+^ T regulatory cells (Tregs) holds promise as an alternative to immunosuppressants. Tregs